WILMINGTON, N.C., June 3 Inclinix, Inc. a contractresearch organization that hires physicians and recruits patients for theclinical trials of new drugs, today announced restructuring of positions tosupport continued growth. Inclinix previously announced a growth rate of 40%in 2007 and the infusion of $10 million in expansion funding, which came inJanuary from Frontier Capital, a private equity firm.
Diane Montross will assume a newly created position, Director of PatientRecruitment. Diane will be responsible for strategically positioning theproducts and services that support clinical trial enrollment and facilitatingcustomized solutions. Having spent the previous six years with VeritasMedicine as the Director of Media Services, Diane's expertise and industryrelationships will be primarily focused toward expanding online patientrecruitment and advocacy efforts.
Tobin Geatz, President and Chief Executive Officer of Inclinix, said, "Weare delighted that Diane joined the company. She has years of online outreachexperience for patients. Now, she will apply her expertise to make our patientoutreach programs the best in the industry."
Inclinix's rapid expansion has driven several other internal promotions:
Steve Agnoff has assumed the role of Senior Vice President of Sales andMarketing. He will closely integrate the sales and marketing efforts to drivecorporate expansion.
Susan Jalbert has assumed the role of Vice President of Sales. Ms. Jalbertprovides strategic direction for a team of business development personnelcovering the U.S. and abroad.
Bill Gwinn has assumed the role of Vice President of New ProductDevelopment. Gwinn has already led development of new tools named CriticalPopulation Research (CPR(R)). CPR supports feasibility studies, selection ofthe best trial sites, and optimization of advertising to recruit patients.
Overall employment is growing with increasing sales. Inclinix willmaintain its headquarters in Wilmington, NC, but will expand to largerfacilities this summer.
Founded in 1999, Inclinix, Inc., is the industry's enrollment CRO. ItsIQM(TM) enrollment process uses technology to identify, qualify, and managepatients for the clinical trials of new medical therapies. Clients includepharmaceutical, biotechnology and medical-device organizations. In addition,Inclinix provides strategic medical marketing communications and adherenceservices to the healthcare industry. For more information on Inclinix, visitwww.inclinix.com .
SOURCE Inclinix, Inc.